Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer. - Wikidata - wikimedia - TriplyDB

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

http://www.wikidata.org/entity/Q30009425

about

MicroRNA-29a plays a suppressive role in non-small cell lung cancer cells via targeting LASP1 MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein Prognostic significance of low microRNA-218 expression in patients with different types of cancer: Evidence from published studies.The impact of pri-miR-218 rs11134527 on the risk and prognosis of patients with esophageal squamous cell carcinoma.MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.MicroRNA-218 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma cells by targeting BMI1.MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.Differentially Expressed MicroRNAs in Meningiomas Grades I and II Suggest Shared Biomarkers with Malignant Tumors.RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.MicroRNA-218 modulates activities of glioma cells by targeting HMGB1.Tumor-suppressive microRNA-218 inhibits tumor angiogenesis via targeting the mTOR component RICTOR in prostate cancer XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.Functional significance of aberrantly expressed microRNAs in prostate cancer.miRNA-186 inhibits prostate cancer cell proliferation and tumor growth by targeting YY1 and CDK6.Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin.Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.MicroRNA-205 inhibits cancer cell migration and invasion via modulation of centromere protein F regulating pathways in prostate cancer.Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.microRNA-32 induces radioresistance by targeting DAB2IP and regulating autophagy in prostate cancer cells.miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.Regulation of actin-binding protein ANLN by antitumor miR-217 inhibits cancer cell aggressiveness in pancreatic ductal adenocarcinoma.Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer.MicroRNA-206 inhibits the viability and migration of medulloblastoma cells by targeting LIM and SH3 protein 1.Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.Impact of novel oncogenic pathways regulated by anti-tumor miR-451a in renal cell carcinoma.MiR-218 suppresses the metastasis and EMT of HCC cells via targeting SERBP1.Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma.MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1.MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF.

P2860

Q30008813-D778E472-736A-405A-AEFA-DB3563C74B27 Q30008853-C16263C8-B3EB-4F8E-8E7A-0C34C3FB968C Q30008871-2FA36E2F-8CED-45E2-8B8C-8EA9952FC8EC Q30009240-00E29C4D-E9B8-4210-AF2A-4F541B94CE82 Q30245349-60B402B7-49DF-4A1F-9010-D73EEDE2F944 Q34371709-72598CBD-8C44-48F4-B5B1-6B300FF7439B Q35678702-B8C86613-4FBD-4896-A0AF-29745D51DA90 Q35827610-6A05A2F6-641A-48A1-BEFA-EA7BF484DD6F Q35919064-FDE7642A-4912-4B07-8847-483E94FF2097 Q35947699-B91F43F2-F50E-4CE0-84C1-A60273B8018E Q36131618-0DAE70CE-9B30-44B7-A8F1-C1D2D0537998 Q36908874-D86FA2A2-DD6F-4179-B3B2-12A97C27D91C Q37293145-68EE4985-28AB-4C21-B97B-4901DB0AED1B Q37702680-652D0C7C-0D40-4F39-B124-22515FEE4938 Q37725519-D2C21285-F26F-4069-B121-45BF60AB7494 Q38323461-12B35FE3-4D93-4003-87EE-1D9A6CF6DFE0 Q38701099-22F294A8-988D-4170-A53D-C802E66349DD Q38765720-587F0341-18A7-4F02-86E0-6F39C17D93C2 Q38769219-55C52708-07D2-430E-96C2-C2EA7166A81F Q38816103-CCD0FB49-7910-451B-937F-BDA716CFE1E8 Q38818816-9C683580-6037-414D-B228-782AF72541B4 Q38824206-0D23F7C5-B1A3-4E69-BB2D-687957872792 Q38826075-EBD665BA-FFA7-4C8A-8996-56878D5650B6 Q38839158-7C7F75DF-102B-47D8-AD9A-0B34DC26D9A4 Q38861461-36FEF80F-D356-466B-BA17-6903D5D6624D Q38865588-C09BE8E0-E26F-4303-A342-AAC38A3BB266 Q39384713-0DA0508F-3DE3-4A36-AE70-2405A85A3830 Q40257658-60D367E3-A58A-4D22-999A-1C7CEDCD2754 Q41082524-DC3D44B4-59C3-4C25-8F74-8C9EA81932E0 Q41593099-709606CC-095E-47B8-B742-F3943B5D5D0A Q41684266-42C2C5C4-3FD5-4154-BA92-6E90AD3A8713 Q42376442-21DBB76D-EE04-4397-8002-188417E2EAE4 Q47426573-47EAB72A-B387-4420-B3F2-A4B8290E2D36 Q48193099-09CDEFBD-C5A1-45E7-9B61-E92A4F7E395A Q50124873-89202589-DA46-45E2-85F4-41C414A71E2B Q51075372-D8436EEB-AF27-4E38-B265-069FD6639083 Q52334742-25DABE72-EF9E-40F8-8BCE-628580156513 Q52685797-BE5B1E90-1E96-47AC-B5A3-C8EEAED28332 Q53508904-CF342D5C-C96C-47AC-B420-062C1838FCD3 Q55453435-FF1CFA15-7C14-478F-85F8-87E397D374D0

P2860

Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancer.

http://www.wikidata.org/entity/Q30009425

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@ast

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@en

type

label

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@ast

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@en

prefLabel

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@ast

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@en

P1433

Q30009425-6AEB88EC-1DDD-46B5-8EED-F8E77C398ADB

P1476

Q30009425-CCFAE23F-CC5D-47CC-9B76-9E692655CF2C

P2093

Q30009425-06FC9EA2-68F1-4004-A884-7AFC41676BF9

Q30009425-21F8E269-3307-496B-B62A-62F116D02C2F

Q30009425-2FEC1DF6-B553-4BFC-9777-9AB7693BB40E

Q30009425-327AD623-4120-4E76-BA41-1EADD88F8739

Q30009425-5435F345-564E-47ED-9486-E29D601D577E

Q30009425-63BF1E09-3F97-4AE3-AD6A-5DF6188D20B5

Q30009425-6D76BB2E-C046-45D8-95F7-37A87255050B

Q30009425-732572E8-86AC-48C4-8300-B352116A414C

Q30009425-7DFBB417-E24C-45A2-88DD-BE0AB8D8F37D

Q30009425-94165A68-46F6-4179-B6C9-567A7BBBB854

P2860

Q30009425-068CC4BF-69E2-4D60-BEA0-CF8EFCCBA955

Q30009425-0D3308CC-A658-49A2-88B9-A7452D87DFA3

Q30009425-13D67453-0033-4793-B512-2252BA06BF10

Q30009425-230E63F0-2C23-4926-ACC6-2D8EB23383CB

Q30009425-4C0848DE-2043-444F-85DD-97A904292BDD

Q30009425-50CC395E-041A-4790-8B3C-8D1069F4EA60

Q30009425-5FA897B0-3E31-41F1-9001-6603B5D45E6C

Q30009425-6278B968-6673-4B72-9DDA-0ABA75FBB3EC

Q30009425-692236E2-F90A-4239-9609-E82F275ECA9D

Q30009425-6F77FC41-21A2-4DC3-BE56-40D71241451D

P304

Q30009425-70FEE4BF-64A3-4EFF-862F-448B568428C2

P31

Q30009425-552DBBA8-8EB4-479C-B544-B88C2959C78C

P3181

Q30009425-380AEED3-E925-4076-A65A-F4D9541E8316

P356

Q30009425-F2B72ACC-10F7-41C8-A79E-19FA788DAEF6

P433

Q30009425-306D8168-C664-4EE0-ADED-57FC9D32E620

P478

Q30009425-28CF4DB2-1D7C-434B-9A26-F95E0251DAEE

P577

Q30009425-A913ECCB-A776-4ABE-B90A-4B39E7375943

P5875

Q30009425-FCA7DEE7-9D51-4446-A809-77069D496452

P698

Q30009425-28B1CB86-84E7-4BF4-B6E4-F1900A93AE31

P921

Q30009425-55170CF4-47A8-41E4-959F-85A72F01ADEC

P932

Q30009425-838EDB9D-DCAB-48BB-8DC0-78DE9CE20495

P3181

P356

P1433

P1476

Tumor-suppressive microRNA-218 ...... g of LASP1 in prostate cancer.

@en

P2093

Hideki Enokida

http://www.w3.org/2001/XMLSchema#string

Masayuki Nakagawa

http://www.w3.org/2001/XMLSchema#string

Naohiko Seki

http://www.w3.org/2001/XMLSchema#string

Noriko Yamamoto

http://www.w3.org/2001/XMLSchema#string

Rika Nishikawa

http://www.w3.org/2001/XMLSchema#string

Satoko Kojima

http://www.w3.org/2001/XMLSchema#string

Shinichi Sakamoto

http://www.w3.org/2001/XMLSchema#string

Takashi Kinoshita

http://www.w3.org/2001/XMLSchema#string

Takeshi Chiyomaru

http://www.w3.org/2001/XMLSchema#string

Tomohiko Ichikawa

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17

Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains

miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer

Most mammalian mRNAs are conserved targets of microRNAs

Cancer statistics, 2013

Origins and Mechanisms of miRNAs and siRNAs

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

MicroRNAs: genomics, biogenesis, mechanism, and function

The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer

Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1

P304

802-811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1613026

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/CAS.12441

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262197696

http://www.w3.org/2001/XMLSchema#string

P698

24815849

http://www.w3.org/2001/XMLSchema#string

P921

P932

4317931

http://www.w3.org/2001/XMLSchema#string